Search research articles
Contact Us
Filters
Showing results (41-50 of 63) with videos related to
Page
of 7
Sort By:
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 19, 2023
Response to the Comment on "Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients"
Matthieu Lilamand, Elodie Bouaziz-Amar, Julien Dumurgier, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 28, 2022
Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients
Matthieu Lilamand, Elodie Bouaziz-Amar, Julien Dumurgier, et al.
Clinical Chemistry and Laboratory Medicine
|
August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid
Elodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
Matthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Alzheimer'S Research & Therapy
|
March 30, 2019
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease
Adla Boumenir, Emmanuel Cognat, Severine Sabia, et al.
Journal of the American Medical Directors Association
|
September 28, 2016
Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians
Natalia Del Campo, Matteo Cesari, Marco Canevelli, et al.
Metabolic Brain Disease
|
June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic
Louise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Neurobiology of Disease
|
December 3, 2022
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study
Karl Götze, Agathe Vrillon, Elodie Bouaziz-Amar, et al.
Ebiomedicine
|
April 16, 2025
Dissection of blood-brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders
Agathe Vrillon, Nicholas J Ashton, Elodie Bouaziz-Amar, et al.
Journal of Neurology
|
March 24, 2026
Eligibility for lecanemab treatment in a French memory clinic setting
Agathe Vrillon, Karl Götze, Julien Dumurgier, et al.
Page
of 7
Search research articles
Search
Showing results (41-50 of 63) with videos related to
Sort By:
Page
of 7
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
May 19, 2023
Response to the Comment on "Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients"
Matthieu Lilamand, Elodie Bouaziz-Amar, Julien Dumurgier, et al.
The Journals of Gerontology. Series A, Biological Sciences and Medical Sciences
|
November 28, 2022
Plasma Leptin Is Associated With Amyloid CSF Biomarkers and Alzheimer's Disease Diagnosis in Cognitively Impaired Patients
Matthieu Lilamand, Elodie Bouaziz-Amar, Julien Dumurgier, et al.
Clinical Chemistry and Laboratory Medicine
|
August 30, 2025
Cerebrospinal fluid leptin in Alzheimer's disease: relationship to plasma levels and to cerebrospinal amyloid
Elodie Bouaziz-Amar, Jeanne Neez, Fidaa Ibrahim, et al.
International Journal of Molecular Sciences
|
November 11, 2022
Cerebrospinal Fluid Alpha-Synuclein Improves the Differentiation between Dementia with Lewy Bodies and Alzheimer's Disease in Clinical Practice
Matthieu Lilamand, Josué Clery, Agathe Vrillon, et al.
Alzheimer'S Research & Therapy
|
March 30, 2019
CSF level of β-amyloid peptide predicts mortality in Alzheimer's disease
Adla Boumenir, Emmanuel Cognat, Severine Sabia, et al.
Journal of the American Medical Directors Association
|
September 28, 2016
Refining Mild-to-Moderate Alzheimer Disease Screening: A Tool for Clinicians
Natalia Del Campo, Matteo Cesari, Marco Canevelli, et al.
Metabolic Brain Disease
|
June 26, 2026
Plasma and CSF adiponectin levels in biomarker-confirmed Alzheimer's disease: A cross-sectional study in a tertiary memory clinic
Louise Sindzingre, Théodore Decaix, Karl Gotze, et al.
Neurobiology of Disease
|
December 3, 2022
Plasma neurofilament light chain in memory clinic practice: Evidence from a real-life study
Karl Götze, Agathe Vrillon, Elodie Bouaziz-Amar, et al.
Ebiomedicine
|
April 16, 2025
Dissection of blood-brain barrier dysfunction through CSF PDGFRβ and amyloid, tau, neuroinflammation, and synaptic CSF biomarkers in neurodegenerative disorders
Agathe Vrillon, Nicholas J Ashton, Elodie Bouaziz-Amar, et al.
Journal of Neurology
|
March 24, 2026
Eligibility for lecanemab treatment in a French memory clinic setting
Agathe Vrillon, Karl Götze, Julien Dumurgier, et al.
Page
of 7